Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation

20161,890 citationsJournal Articlebronze Open Access

Authors

Karl-Heinz Kuck · Asklepios Klinik St. Georg

Josép Brugada · Universitat de Barcelona

Alexander Fürnkranz

Andreas Metzner · Asklepios Klinik St. Georg

Feifan Ouyang · Asklepios Klinik St. Georg

K. R. Julian Chun

Arif Elvan · Isala

Thomas Arentz ·

Abstract

In this randomized trial, cryoballoon ablation was noninferior to radiofrequency ablation with respect to efficacy for the treatment of patients with drug-refractory paroxysmal atrial fibrillation, and there was no significant difference between the two methods with regard to overall safety. (Funded by Medtronic; FIRE AND ICE ClinicalTrials.gov number, NCT01490814.).

Topics & Keywords

Atrial Fibrillation Management and Outcomes Cardiac Arrhythmias and Treatments Cardiac electrophysiology and arrhythmias

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 374, Issue 23, pp. 2235-2245

DOI: 10.1056/nejmoa1602014

Field-Weighted Citation Impact: 139.38